Agenda

View Conference Video

Friday, February 2, 2024  |  7:00 am - 4:00 pm
In Person  or Virtually 
Hilton Philadelphia City Avenue
4200 City Avenue, Philadelphia, PA, 19131

Download Syllabus

7:00 am

IN-PERSON: Check In, Continental Breakfast, Visit Exhibits and Experts

7:45 am

VIRTUAL: Log in to Virtual Conference

8:00 am

Welcome and Introductions

Edward A. Stadtmauer, MD  |  Activity Director

Robert H. Vonderheide, MD, DPhil  |  Director, Abramson Cancer Center

8:10 am

Keynote Address: Use and Interpretation of Molecular Genetics in Blood Cancers Morrissette

Jennifer J.D. Morrissette, PhD  |  Pathology and Laboratory Medicine

NEW THERAPIES AND CURRENT PATIENT MANAGEMENT OF LYMPHOMAS

MODERATOR: Stephen J. Schuster, MD  |  Activity Co-Director

8:40 am

Novel Therapies in Follicular and Marginal Zone Lymphomas

Jordan S. Carter, MD

8:55 am

Advances in CLL and Mantle Cell Lymphoma

Elise A. Chong, MD

9:10 am

Updates in Management of Hodgkin Lymphoma

Jakub Svoboda, MD  |  Activity Co-Director

9:25 am

Therapeutic Advances in T-Cell Lymphomas

Stefan K. Barta MD, MS, MRCPCUK

9:40 am

Targeted Therapy of Aggressive B-Cell Lymphomas

Daniel J. Landsburg, MD

9:55 am

Evolving Role of Immune Modulation Therapies including CAR T and Bispecific Antibodies and New Antibodies in Lymphoma Management

Sunita D. Nasta, MD, FACP

10:15 am

Panel Discussion

MODERATOR: Stephen J. Schuster, MD  |  Activity Co-Director

PANEL:

Stefan K. Barta MD, MS, MRCPCUK

Jordan S. Carter, MD

Elise A. Chong, MD

Michael R. Cook, MD

Gamil S. Hanna, MD

Mitchell E. Hughes, Pharm.D., BCOP | Oncology Pharmacy

Daniel J. Landsburg, MD

Danielle Land, MSN, CRNP

Sunita D. Nasta, MD, FACP

John P. Plastaras, MD, PhD  |  Radiation Oncology

Colin J. Thomas, MD

Emily Tomasulo, DO

Jakub Svoboda, MD  |  Activity Co-Director

10:45 am                         

Break and Visit Exhibits

UPDATE IN BLOOD, MARROW TRANSPLANTATION AND CELLULAR THERAPY

MODERATORS: Nasheed M. Hossain, MD  |  Activity Co-Director

10:55 am

Updates in Cellular Therapy for Sickle Cell Disease and Beta-Thalassemia

Scott A. Peslak, MD, PhD 

11:10 am

Alternative Donor Options

Shannon R. McCurdy, MD

11:25 am

New Approaches to Preventing and Treating GVHD

Pashna Munshi, MD

11:40 am

MODERATORS: Nasheed M. Hossain, MD  |  Activity Co-Director

PANEL:

Noelle V. Frey, MD

Nasheed M. Hossain, MD  |  Activity Co-Director

Shannon R. McCurdy, MD

Linda M. Perry, MS, PA-C

John P. Plastaras, MD, PhD  |  Radiation Oncology

11:55 am

Lunch Break and Visit Exhibits

UPDATE ON PATIENT CARE TREATMENT STRATEGIES IN LEUKEMIA

Moderator: Catherine E. Lai, MD, MPH  |  Activity Co-Director

​​​​​​​12:25 pm         

Emerging Treatment Options for AML

Alexander E. Perl, MD

12:40 pm

MDS / Hereditary Myeloid Disorders

Ximena Jordan-Bruno, MD

​​​​​​​12:55 pm

Update in CML and Myeloproliferative Disease

Elizabeth O. Hexner, MD, MSTR

1:10 pm

Immunotherapies of Acute Leukemias

Catherine E. Lai, MD, MPH  |  Activity Co-Director

1:25 pm

Panel Discussion

MODERATORS: Keith W. Pratz, MD  |  Activity Co-Director

PANEL:

Alison Carulli, PharmD  |  Oncology Pharmacy

Elizabeth O. Hexner, MD, MSTR

Ximena Jordan-Bruno, MD 

Catherine E. Lai, MD, MPH  |  Activity Co-Director

Lindsay M. Lee, MSN, CRNP

Selina M. Luger, MD

Alexander E. Perl, MD

John P. Plastaras, MD, PhD  |  Radiation Oncology

Sunil Saroha, MD

 

CONTROVERSIES AND UPDATE FOR PATIENT CARE IN MULTIPLE MYELOMA

Moderator: Edward A. Stadtmauer, MD  |  Activity Director

1:45 pm

Smoldering Myeloma and Amyloidosis

Sandra P. Susanibar-Adaniya, MD

2:10 pm

Initial Therapy for Multiple Myeloma Including Transplant

Alfred L. Garfall, MD, MS

2:30 pm

Role of Immunotherapy for Myeloma

Adam D. Cohen, MD

2:50 pm

Experimental Therapies for Relapsed Myeloma

Dan T. Vogl, MD, MSCE

3:10 pm

Panel Discussion

MODERATOR: Edward A. Stadtmauer, MD  |  Activity Director

PANEL:

Shivani Bakhshi, DO

Adam D. Cohen, MD

Alfred L. Garfall, MD

Shivani Kapur, MD

Oxana Megherea, PharmD  |  Oncology Pharmacy

John P. Plastaras, MD, PhD  |  Radiation Oncology

Leah R. Power, MSN, CRNP

Sandra P. Susanibar-Adaniya, MD

Dan T. Vogl, MD, MSCE
Adam Waxman, MD, MS

 

 

3:45 pm

Adjourn